• Something wrong with this record ?

Formulation optimization and evaluation of oromucosal in situ gel loaded with silver nanoparticles prepared by green biosynthesis

S. Rohaľová, T. Wolaschka, Ľ. Balážová, K. Paulovičová, J. Tóthová, S. Pavloková, M. Stahorský, J. Gajdziok

. 2024 ; 193 (-) : 106683. [pub] 20231222

Language English Country Netherlands

Document type Journal Article

Treating oral diseases remains challenging as API is quickly washed out of the application site by saliva turnover and mouth movements. In situ gels are a class of application forms that present sol-gel transition's ability as a response to stimuli. Their tunable properties are provided using smart polymers responsible for stimuli sensitivity, often providing mucoadhesivity. In this study, antimicrobial in situ gels of thermosensitive and pH-sensitive polymers loaded with silver nanoparticles were prepared and evaluated. The nanoparticles were prepared by green synthesis using Agrimonia eupatoria L. extract. According to the data analysis, the in situ gel with the most promising profile contained 15 % of Pluronic® F-127, 0.25 % of methylcellulose, and 0.1 % of Noveon® AA-1. Pluronic® F-127 and methylcellulose significantly increased the viscosity of in situ gels at 37 °C and shear rates similar to speaking and swallowing. At 20 °C, a behavior close to a Newtonian fluid was observed while being easily injectable (injection force 13.455 ± 1.973 N). The viscosity of the formulation increased with temperature and reached 2962.77 ± 63.37 mPa·s (37 °C). A temperature increase led to increased adhesiveness and rigidity of the formulation. The critical sol-gel transition temperature at physiological pH was 32.65 ± 0.35 °C. 96.77 ± 3.26 % of Ag NPs were released by erosion and dissolution of the gel after 40 min. The determination of MIC showed effect against E. coli and S. aureus (0.0625 mM and 0.5000 mM, respectively). The relative inhibition zone diameter of the in situ gel was 73.32 ± 11.06 % compared to gentamicin sulfate. This work discusses the optimization of the formulation of novel antibacterial in situ gel for oromucosal delivery, analyses the impact of the concentration of excipients on the dependent variables, and suggests appropriate evaluation of the formulation in terms of its indication. This study offers a promising dosage form for local treatment of oral diseases.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24007325
003      
CZ-PrNML
005      
20240423155857.0
007      
ta
008      
240412e20231222ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.ejps.2023.106683 $2 doi
035    __
$a (PubMed)38142949
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Rohaľová, Simona $u Department of Pharmaceutical Technology, Faculty of Pharmacy, Masaryk University, Palackého třída 1946/1 612 00 Brno, Czech Republic; Department of Pharmaceutical Technology, Pharmacognosy and Botany, University of Veterinary Medicine and Pharmacy in Košice, Komenského 73 041 81 Košice, Slovak Republic
245    10
$a Formulation optimization and evaluation of oromucosal in situ gel loaded with silver nanoparticles prepared by green biosynthesis / $c S. Rohaľová, T. Wolaschka, Ľ. Balážová, K. Paulovičová, J. Tóthová, S. Pavloková, M. Stahorský, J. Gajdziok
520    9_
$a Treating oral diseases remains challenging as API is quickly washed out of the application site by saliva turnover and mouth movements. In situ gels are a class of application forms that present sol-gel transition's ability as a response to stimuli. Their tunable properties are provided using smart polymers responsible for stimuli sensitivity, often providing mucoadhesivity. In this study, antimicrobial in situ gels of thermosensitive and pH-sensitive polymers loaded with silver nanoparticles were prepared and evaluated. The nanoparticles were prepared by green synthesis using Agrimonia eupatoria L. extract. According to the data analysis, the in situ gel with the most promising profile contained 15 % of Pluronic® F-127, 0.25 % of methylcellulose, and 0.1 % of Noveon® AA-1. Pluronic® F-127 and methylcellulose significantly increased the viscosity of in situ gels at 37 °C and shear rates similar to speaking and swallowing. At 20 °C, a behavior close to a Newtonian fluid was observed while being easily injectable (injection force 13.455 ± 1.973 N). The viscosity of the formulation increased with temperature and reached 2962.77 ± 63.37 mPa·s (37 °C). A temperature increase led to increased adhesiveness and rigidity of the formulation. The critical sol-gel transition temperature at physiological pH was 32.65 ± 0.35 °C. 96.77 ± 3.26 % of Ag NPs were released by erosion and dissolution of the gel after 40 min. The determination of MIC showed effect against E. coli and S. aureus (0.0625 mM and 0.5000 mM, respectively). The relative inhibition zone diameter of the in situ gel was 73.32 ± 11.06 % compared to gentamicin sulfate. This work discusses the optimization of the formulation of novel antibacterial in situ gel for oromucosal delivery, analyses the impact of the concentration of excipients on the dependent variables, and suggests appropriate evaluation of the formulation in terms of its indication. This study offers a promising dosage form for local treatment of oral diseases.
650    12
$a poloxamer $x chemie $7 D020442
650    _2
$a stříbro $7 D012834
650    _2
$a Escherichia coli $7 D004926
650    12
$a kovové nanočástice $7 D053768
650    _2
$a Staphylococcus aureus $7 D013211
650    _2
$a teplota $7 D013696
650    _2
$a gely $x chemie $7 D005782
650    _2
$a methylcelulosa $7 D008747
655    _2
$a časopisecké články $7 D016428
700    1_
$a Wolaschka, Tomáš $u Department of Pharmaceutical Technology, Pharmacognosy and Botany, University of Veterinary Medicine and Pharmacy in Košice, Komenského 73 041 81 Košice, Slovak Republic
700    1_
$a Balážová, Ľudmila $u Department of Pharmaceutical Technology, Pharmacognosy and Botany, University of Veterinary Medicine and Pharmacy in Košice, Komenského 73 041 81 Košice, Slovak Republic
700    1_
$a Paulovičová, Katarína $u Institute of Experimental Physics, Slovak Academy of Sciences, Watsonova 47 040 01 Košice, Slovak Republic
700    1_
$a Tóthová, Jana $u Department of Physics, Faculty of Electrical Engineering and Informatics, Technical University of Košice, Park Komenského 2 042 00 Košice, Slovak Republic
700    1_
$a Pavloková, Sylvie $u Department of Pharmaceutical Technology, Faculty of Pharmacy, Masaryk University, Palackého třída 1946/1 612 00 Brno, Czech Republic
700    1_
$a Stahorský, Martin $u Institute of Geotechnics, Slovak Academy of Sciences, Watsonova 45 040 01 Košice, Slovak Republic
700    1_
$a Gajdziok, Jan $u Department of Pharmaceutical Technology, Faculty of Pharmacy, Masaryk University, Palackého třída 1946/1 612 00 Brno, Czech Republic. Electronic address: gajdziokj@pharm.muni.cz
773    0_
$w MED00001639 $t European journal of pharmaceutical sciences $x 1879-0720 $g Roč. 193 (20231222), s. 106683
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38142949 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240412 $b ABA008
991    __
$a 20240423155854 $b ABA008
999    __
$a ok $b bmc $g 2081356 $s 1217092
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 193 $c - $d 106683 $e 20231222 $i 1879-0720 $m European journal of pharmaceutical sciences $n Eur. j. pharm. sci. (Print) $x MED00001639
LZP    __
$a Pubmed-20240412

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...